Stock Report

Fredun Pharmaceuticals Ltd Q3 FY2023 PAT increases to Rs. 3.45 crore

Posted On : 2023-01-27 20:30:52( TIMEZONE : IST )

Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 77.9559 crores during the period ended December 31, 2022 as compared to Rs. 70.3227 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 3.4567 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 3.1527 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 7.66 for the period ended December 31, 2022 as compared to Rs. 7.11 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹77.9559 crs	₹70.3227 crs	10.85%
Net Profit	₹3.4567 crs	₹3.1527 crs	9.64%
EPS	₹7.66	₹7.11	7.74%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.77.9559 crores during the period ended December 31, 2022 as compared to Rs.54.2325 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.3.4567 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.1.8716 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.7.66 for the period ended December 31, 2022 as compared to Rs.4.22 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹77.9559 crs	₹54.2325 crs	43.74%
Net Profit	₹3.4567 crs	₹1.8716 crs	84.69%
EPS	₹7.66	₹4.22	81.52%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.77.9559 crores during the 9 Months period ended December 31, 2022 as compared to Rs.154.2443 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.3.4567 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.4.0396 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.7.66 for the 9 Months period ended December 31, 2022 as compared to Rs.10.13 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹77.9559 crs	₹154.2443 crs	-49.46%
Net Profit	₹3.4567 crs	₹4.0396 crs	-14.43%
EPS	₹7.66	₹10.13	-24.38%

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 989.00 as compared to the previous close of Rs. 999.30. The total number of shares traded during the day was 2909 in over 170 trades.

The stock hit an intraday high of Rs. 1010.00 and intraday low of 972.00. The net turnover during the day was Rs. 2872216.00.